Literature DB >> 26073439

Global cognitive function before, surrounding, and after ischemic stroke: the role of risk and protective factors varies with time among ischemic stroke survivors.

Leslie Vaughan1, Cheryl Bushnell2, Christina L Bell3, Mark A Espeland4.   

Abstract

An estimated 65% of individuals demonstrate multidomain cognitive impairment poststroke, although little is known about the varying role of cognitive risk and protective factors in preischemic, peri-ischemic, and postischemic stroke phases. Longitudinal changes in global cognitive function after ischemic stroke are not well characterized, especially in older adults over age 80. We examined global cognitive function trajectories in these three phases across a mean follow-up of 8.12 (2.30) years in 159 female stroke survivors aged 65-79 at baseline using linear mixed models with change points. In separate models controlling for demographic variables, we tested the interaction of baseline risk and protective factors with stroke phase on global cognitive function. None of the prestroke global cognitive function means or trajectories differed significantly. At the time of ischemic stroke, higher body mass index (BMI), the presence of hypertension (HTN), low optimism, and higher physical function were all associated with significantly greater mean decreases in global cognition (all p's <.0.0001), but were not significantly different from the contrasting level (all p's >0.05). Higher BMI, the presence of HTN, low optimism, and higher physical function were in turn protective of global cognitive decline postischemic stroke (all contrasting p values <.01). Baseline factors may play either a risk or a protective role in global cognitive function depending on the phase of ischemic stroke.

Entities:  

Keywords:  aging; global cognitive function; ischemic; longitudinal; stroke

Mesh:

Year:  2015        PMID: 26073439      PMCID: PMC4916645          DOI: 10.1080/13825585.2015.1058323

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  48 in total

1.  Blood pressure parameters and carotid intraplaque hemorrhage as measured by magnetic resonance imaging: The Rotterdam Study.

Authors:  Mariana Selwaness; Quirijn J A van den Bouwhuijsen; Germaine C Verwoert; Abbas Dehghan; Francesco U S Mattace-Raso; Meike Vernooij; Oscar H Franco; Albert Hofman; Aad van der Lugt; Jolanda J Wentzel; Jacqueline C M Witteman
Journal:  Hypertension       Date:  2012-12-03       Impact factor: 10.190

2.  Evolution of cognitive impairment after stroke and risk factors for delayed progression.

Authors:  Teodoro del Ser; Raquel Barba; Maria M Morin; Julio Domingo; Carlos Cemillan; Margarita Pondal; Jose Vivancos
Journal:  Stroke       Date:  2005-10-27       Impact factor: 7.914

3.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

4.  Mild cognitive impairment and vascular cognitive impairment in stroke patients.

Authors:  Clive Ballard; Sally Stephens; Andrew McLaren; Keith Wesnes; RoseAnne Kenny
Journal:  Int Psychogeriatr       Date:  2003       Impact factor: 3.878

5.  Short version of the CES-D (Burnam screen) for depression in reference to the structured psychiatric interview.

Authors:  A Tuunainen; R D Langer; M R Klauber; D F Kripke
Journal:  Psychiatry Res       Date:  2001-09-20       Impact factor: 3.222

6.  Poststroke dementia : clinical features and risk factors.

Authors:  R Barba; S Martínez-Espinosa; E Rodríguez-García; M Pondal; J Vivancos; T Del Ser
Journal:  Stroke       Date:  2000-07       Impact factor: 7.914

7.  Frequency of depression after stroke: a systematic review of observational studies.

Authors:  Maree L Hackett; Chaturangi Yapa; Varsha Parag; Craig S Anderson
Journal:  Stroke       Date:  2005-05-05       Impact factor: 7.914

8.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

Authors:  Sylvia Wassertheil-Smoller; Susan L Hendrix; Marian Limacher; Gerardo Heiss; Charles Kooperberg; Alison Baird; Theodore Kotchen; J David Curb; Henry Black; Jacques E Rossouw; Aaron Aragaki; Monika Safford; Evan Stein; Somchai Laowattana; W Jerry Mysiw
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

9.  Ensuring reliability of outcome measures in multicenter clinical trials of treatments for acute ischemic stroke. The program developed for the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Authors:  M A Albanese; W R Clarke; H P Adams; R F Woolson
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

10.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  3 in total

1.  Protective effect of α-terpineol against impairment of hippocampal synaptic plasticity and spatial memory following transient cerebral ischemia in rats.

Authors:  Mahsa Moghimi; Siavash Parvardeh; Taraneh Moini Zanjani; Shiva Ghafghazi
Journal:  Iran J Basic Med Sci       Date:  2016-09       Impact factor: 2.699

2.  Cognitive improvement following ischemia/reperfusion injury induced by voluntary running‑wheel exercise is associated with LncMALAT1‑mediated apoptosis inhibition.

Authors:  Jin-Lin Shang; Qing Cheng; Sheng-Jie Duan; Lu Li; Li-Ya Jia
Journal:  Int J Mol Med       Date:  2018-02-12       Impact factor: 4.101

Review 3.  The neuroprotective mechanisms of ginkgolides and bilobalide in cerebral ischemic injury: a literature review.

Authors:  Zili Feng; Qian Sun; Wang Chen; Yu Bai; Daihua Hu; Xin Xie
Journal:  Mol Med       Date:  2019-12-21       Impact factor: 6.354

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.